Biotech Stocks Have Colds, but They Can Heal

This year hasn’t been kind to biotechnology stocks and related exchange traded funds. The headwinds faced by these assets were ratcheted up last week when the Biden administration revealed plans to pursue lower drug prices. As a result, the ALPS Medical Breakthroughs ETF (SBIO) lost 1.81% on...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.